Connect with us

Health

Successful SARS-CoV-2 vaccination hinges on non-pharmaceutical interventions and vaccine deployment strategies – News-Medical.Net

A thought-provoking new study server discusses the factors that determine the successful use of available vaccines to mitigate incidence and mortality rates for…

Published

on

Article feature image

The accelerated rate of vaccine development against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in an attempt to bring an end to the coronavirus disease 2019 (COVID-19) pandemic, culminated in the approval of the Pfizer/BioNTech and Moderna vaccines under Emergency Use Authorization by the US Food and Drug Administration, as well as its European counterparts.
Both vaccines claim 95% efficacy after two doses, given three and four weeks apart for the Pfizer and Moderna vaccines,…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
Calls for some telehealth services to become permanent after millions use virtual service during COVID pandemic – ABC News
Article feature image
Fighting one of the world’s biggest killers during a pandemic – UNDP